Senseonics Holdings, Inc. Common Stock $SENS Shares Sold by GMT Capital Corp

GMT Capital Corp lessened its stake in Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) by 95.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 36,468 shares of the company’s stock after selling 692,909 shares during the quarter. GMT Capital Corp’s holdings in Senseonics Holdings, Inc. Common Stock were worth $201,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Masters Capital Management LLC raised its stake in shares of Senseonics Holdings, Inc. Common Stock by 11.1% in the 3rd quarter. Masters Capital Management LLC now owns 5,000,000 shares of the company’s stock valued at $2,179,000 after purchasing an additional 500,000 shares in the last quarter. Squarepoint Ops LLC grew its position in shares of Senseonics Holdings, Inc. Common Stock by 8.4% during the 3rd quarter. Squarepoint Ops LLC now owns 751,916 shares of the company’s stock valued at $328,000 after buying an additional 57,951 shares during the last quarter. Sei Investments Co. grew its position in shares of Senseonics Holdings, Inc. Common Stock by 13.0% during the 3rd quarter. Sei Investments Co. now owns 1,804,913 shares of the company’s stock valued at $787,000 after buying an additional 208,314 shares during the last quarter. UBS Group AG grew its position in shares of Senseonics Holdings, Inc. Common Stock by 409.0% during the 3rd quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock valued at $1,852,000 after buying an additional 3,413,866 shares during the last quarter. Finally, Vanguard Group Inc. grew its position in shares of Senseonics Holdings, Inc. Common Stock by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company’s stock valued at $14,920,000 after buying an additional 749,453 shares during the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

Insider Buying and Selling

In other news, Director Douglas A. Roeder bought 22,686 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was purchased at an average price of $5.56 per share, for a total transaction of $126,134.16. Following the transaction, the director owned 144,635 shares in the company, valued at approximately $804,170.60. This trade represents a 18.60% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 4.70% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Trading Down 2.0%

NASDAQ SENS opened at $7.18 on Friday. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $12.58. The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05. The company has a market cap of $300.12 million, a PE ratio of -3.59 and a beta of 1.04. The stock has a 50-day moving average price of $6.50.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its earnings results on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing the consensus estimate of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%.The firm had revenue of $11.71 million during the quarter. As a group, equities research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SENS. HC Wainwright lowered their price objective on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th. Finally, Stifel Nicolaus lowered their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $17.00.

Senseonics Holdings, Inc. Common Stock Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.